CFTR and cystic fibrosis: Unfortunately, SRI-37240 and SRI-41315 had undesirable effects on sodium transport by ENaC other than CFTR, which limits their potential to develop into CF therapeutic drugs [95], but they may be helpful in other disease models that are caused by PTCs.